what happens when you stop glp-1 Stopping GLP-1s: Weight Regain and Maintenance Tips Before & After Semaglutide GLP-1

Resources We Trust Cleveland Clinic: The New Anti-Obesity Drugs: What You Should Know Mayo Clinic: Pros and Cons of GLP-1 Agonists for Weight Loss Harvard Health: Questions and Answers About the New Anti-Obesity Medications Yale Medicine: Why Your Cardiologist May Prescribe Semaglutide (Wegovy) NewYork-Presbyterian: Tirzepatide Shows Powerful Diabetes-Prevention Effect in Three-Year Trial FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or Overweight

doi: 10.1016/j.pharmthera.2020.107503

Am J Med (2014) 127(10):9129

Once FDA approved, orforglipron is scheduled to be available in 2026 at a significantly decreased cost compared to current injectables

If these experiments pan out, we could see clinical trials of drugs specifically tested to protect memory among older people